IPSC Century Therapeutics, Inc.
Price Chart
Executive Summary
Two insiders at Century Therapeutics (IPSC) sold a combined ~$1,632 in open-market sales on June 8, 2026, while five directors received non-cash stock grants of 74,000 shares each on June 11. The open-market sales are trivial at ~0.0004% of the $404M market cap and likely routine liquidity transactions. The director grants are non-cash awards with no economic signal. The cluster is not informative.
Key Financial Metrics
Actionable Insight
Insider activity is immaterial and provides no trading signal. Monitor upcoming clinical data readouts or partnership announcements for catalysts. The director grants suggest routine compensation, not a bearish view.
Key Facts
- Two insiders sold open-market shares totaling ~$1,632 on June 8, 2026
- Five directors received non-cash stock grants of 74,000 shares each on June 11, 2026
- Total open-market sales represent ~0.0004% of $404M market cap — immaterial
- No C-suite executives (CEO/CFO) participated in open-market sales
- Director grants are routine compensation awards with zero cash value
Financial Impact
Open-market sales of ~$1,632 represent 0.0004% of market cap — negligible
Risk Factors
- No material insider conviction signal from this cluster
- Biotech sector risk: clinical trial failures could drive significant downside
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-IPSC-1781298515366 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
5d ago
|
Insider Cluster
| $2.21 awaiting T+5 | awaiting T+5 | — | $2.25 (+1.81%) |
|
Jun 9, 2026
5d ago
|
Insider Cluster
| $2.21 awaiting T+5 | awaiting T+5 | — | $2.25 (+1.81%) |
|
May 13, 2026
4w ago
|
8-K
| $2.28 $2.12 | ▼ −7.02% | ▼ −5.86% | $2.25 (−1.32%) |
|
May 13, 2026
4w ago
|
Press Release
| $2.28 $2.12 | ▼ −7.02% | ▼ −5.86% | $2.25 (−1.32%) |
|
Apr 30, 2026
6w ago
|
Press Release
| $2.31 $2.31 | · 0.00% | ▼ −2.35% | $2.25 (−2.60%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $2.20 $2.29 | ▲ +4.09% | ▲ +2.40% | $2.25 (+2.27%) |
|
Mar 26, 2026
11w ago
|
424B5
| $2.02 $2.19 | ▲ +8.42% | ▲ +4.55% | $2.25 (+11.39%) |
|
Mar 12, 2026
13w ago
|
8-K
| $2.50 $2.49 | ▼ −0.40% | ▲ +0.58% | $2.25 (−10.00%) |
|
Mar 12, 2026
13w ago
|
Press Release
| $2.50 $2.49 | ▼ −0.40% | ▲ +0.58% | $2.25 (−10.00%) |
|
Mar 12, 2026
13w ago
|
Insider Cluster
| $2.50 $2.49 | ▼ −0.40% | ▲ +0.58% | $2.25 (−10.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access